New Developments in the Use of Patient-Reported Outcomes in Cancer Patients Undergoing Immunotherapies. | Adv Exp Med Biol;1244: 335-339, 2020. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

New Developments in the Use of Patient-Reported Outcomes in Cancer Patients Undergoing Immunotherapies.

Mendoza, Tito R.

Affiliation

Mendoza TR; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. tmendoza@mdanderson.org.

Adv Exp Med Biol ; 1244: 335-339, 2020.

Article in En | MEDLINE | ID: mdl-32301027

Subject(s)
Key words

Cancer; Immunotherapy; Patient-reported outcomes; Qualitative research; Recall period; Symptoms

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Patient Reported Outcome Measures / Immunotherapy / Neoplasms Type of study: Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Adv Exp Med Biol Year: 2020 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Patient Reported Outcome Measures / Immunotherapy / Neoplasms Type of study: Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Adv Exp Med Biol Year: 2020 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos